Acro Biomedical (ACBM) EBITDA (2016 - 2025)
Acro Biomedical's quarterly EBITDA came in at -$16377.0 in Q4 2025, down 183.52% year-on-year from $19608.0 in Q4 2024, and up 85.77% quarter-over-quarter from -$115099.0 in Q3 2025.
Acro Biomedical has reported EBITDA for 10 years, with the latest figure at -$16377.0 in Q4 2025.
- For the quarter ending Q4 2025, EBITDA fell 183.52% year-over-year to -$16377.0; the trailing twelve-month figure through Dec 2025 stood at -$154024.0 (down 1634.11% YoY), and the FY2025 full-year result was -$154024.0, down 1634.11% from the prior year.
- EBITDA for Q4 2025 stood at -$16377.0, up from -$115099.0 in the prior quarter.
- The five-year high for EBITDA was $6.9 million in Q4 2023, with the low at -$4.0 million in Q3 2022.
- Average EBITDA over 5 years is -$1.3 million, with a median of -$454209.5 recorded in 2021.
- Year-over-year, EBITDA tumbled 6793.35% in 2022 and jumped 276.35% in 2023.
- Tracing ACBM's EBITDA over 5 years: stood at -$3.9 million in 2021, then fell by 2.11% to -$3.9 million in 2022, then jumped by 276.35% to $6.9 million in 2023, then sank by 99.72% to $19608.0 in 2024, then tumbled by 183.52% to -$16377.0 in 2025.
- The last three EBITDA figures came in at -$16377.0 (Q4 2025), -$115099.0 (Q3 2025), and -$13614.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | -427,850.00 |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | -482,100.00 |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | -201,744.00 |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | -1.15 Mn |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | -612,993.00 |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | -218,386.00 |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | -198,194.00 |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | -811,301.00 |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | -168,092.00 |
| 10 | Acro Biomedical | - | - | - | -16,377.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16,377.00 |
| Sep 30, 2025 | -115,099.00 |
| Jun 30, 2025 | -13,614.00 |
| Mar 31, 2025 | -8,934.00 |
| Dec 31, 2024 | 19,608.00 |
| Sep 30, 2024 | -9,106.00 |
| Jun 30, 2024 | -9,086.00 |
| Mar 31, 2024 | -10,298.00 |
| Dec 31, 2023 | 6.94 Mn |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -3.19 Mn |
| Mar 31, 2023 | -4.00 Mn |
| Dec 31, 2022 | -3.93 Mn |
| Sep 30, 2022 | -4.01 Mn |
| Jun 30, 2022 | -4.00 Mn |
| Mar 31, 2022 | -3.93 Mn |
| Dec 31, 2021 | -3.85 Mn |
| Sep 30, 2021 | -2.99 Mn |
| Jun 30, 2021 | -793,320.00 |
| Mar 31, 2021 | -56,991.00 |
| Sep 30, 2020 | -71,541.00 |
| Jun 30, 2020 | -62,771.00 |
| Mar 31, 2020 | 81,557.00 |
| Dec 31, 2019 | -75,433.00 |
| Sep 30, 2019 | -64,460.00 |
| Jun 30, 2019 | -68,092.00 |
| Mar 31, 2019 | -214,766.00 |
| Dec 31, 2018 | -94,235.00 |
| Sep 30, 2018 | 161,086.00 |
| Jun 30, 2018 | 176,226.00 |
| Mar 31, 2018 | 98,011.00 |
| Dec 31, 2017 | 80,227.00 |
| Sep 30, 2017 | 39,495.00 |
| Jun 30, 2017 | -11,887.00 |
| Mar 31, 2017 | -22,443.00 |
| Dec 31, 2016 | -7,413.00 |